On April 27-28 LifeTec Group will be present at the AATS Mitral Conclave in New York. It would be our great pleasure to welcome you!

LifeTec Group is currently involved in training surgeons worldwide on a new mitral valve repair device, the NeoChord DS1000.

Mitral valve insufficiency is one of the most common types of cardiovascular disease in the Western world. Treatment is often inevitable because in serious cases mitral valve insufficiency can cause heart failure.

'Minimally invasive'

Treatment can literally make the difference between life and death for the patient. There’s a wide range of possible treatments, depending on the kind of heart disease and how serious it is. Until recently, treatment of the most serious cases often meant open heart surgery: an invasive procedure in which the sternum is divided, the heart is temporarily stopped, and a valve is ‘repaired’ or replaced. Not only is this a risky operation, it also involves a very long period of recovery.

The US based medtech company NeoChord developed a medical device (DS1000) with which the insufficiency can be corrected through an alternative, minimally invasive operation:

First, the device is placed inside the body through a small incision, a sternal-sparing left thoracotomy. Next it is guided to the heart, using 3D ultrasonography to establish the precise location. The device clamps onto the mitral valve and attaches new synthetic tendons to it. A beating heart, off pump procedure to minimize complications and have a real-time confirmation of repair. 

Fantastic improvement

NeoChord’s minimally invasive solution is a fantastic improvement as compared to traditional surgery - provided the surgeon has enough experience in working with the device. For this reason, LifeTec Group customized its ‘Passive-Heart bio-simulator’ to meet the demands of the training heart-surgeons with the NeoChord device. Thanks to this bespoke platform, surgeons all over the world now have an opportunity to experience a steep learning curve and gain the necessary experience with what they themselves consider “probably the best simulator model I’ve ever seen”.

 

Testimonial

“probably the best simulator model I’ve ever seen”

Dr. Michael A. Borger 

Columbia NewYork-Presbytarian  

 

close to real

‘Our ‘Passive Heart Bio-simulator Platform’ mimics the real life situation using a real heart.’ Says Dr. Jurgen de Hart (PhD), CEO of the LifeTec Group: ‘We have already trained dozens of surgeons over the past few months. They are all extremely enthusiastic, not only about the new device but certainly also about our Passive Heart Bio-simulator, because it resembles reality so closely.’

Photo: AATS Mitral Conclave Program Director Dr. David H. Adams, and (Mount Sinai Research Professor | Cardiovascular Surgery) Dr. Julie Swain MD have preceded you [photo]

AATS Mitral Conclave Program Director Dr. David H. Adams, and (Mount Sinai Research Professor | Cardiovascular Surgery) Dr. Julie Swain MD have preceded you [photo]

Welcome

It would be our great pleasure to meet you in New York. Visit us at the NeoChord booth and get acquainted with the latest technologies for mitral valve repair: The NeoChord DS1000 minimally invasive Mitral Valve Repair system.

CEO

Jurgen de Hart

Senior Research Engineer

Sjoerd van Tuijl

Schedule a meeting

If you like to schedule a meeting please do not hesitate to call us at: +31 40 2989393

Relevant links and background:

©2021 LifeTec Group.  Legal  Credits